Literature DB >> 3966697

Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia.

S M Albelda, G H Talbot, S L Gerson, W T Miller, P A Cassileth.   

Abstract

The influence of bone marrow recovery on the clinical and radiographic course of invasive pulmonary aspergillosis in patients with acute leukemia has not been well characterized. We studied 26 patients with acute leukemia and invasive pulmonary aspergillosis, comparing those who recovered from chemotherapy-induced granulocytopenia (Group 1, 15 patients) with those who did not (Group 2, 11 patients). Radiographic evidence of pulmonary cavitation was not seen in any Group 2 patient, but developed in 11 of 15 (73%) Group 1 patients (p less than 0.005). In these patients, cavitation always occurred after marrow recovery, an average of 2.0 days (range: 0 to 6 days) after the granulocyte count exceeded 500/mm3. Eight patients in Group 1 and 2 in Group 2 experienced a total of 38 episodes of hemoptysis. Four of the 26 patients, all in Group 1, developed massive hemoptysis (greater than 150 ml of blood per episode), leading to 1 death. In 3 of these 4 patients, cavitation preceded the episode of massive hemoptysis. At the time of massive bleeding, the granulocyte count was greater than 500/mm3, the platelet count greater than 38,000/mm3, and the other coagulation parameters were normal in all 4 patients. Our findings demonstrate that in patients with acute leukemia undergoing chemotherapy, bone marrow recovery markedly influences the clinical and radiographic course of invasive pulmonary aspergillosis. Development of a granulocyte count greater than 500/mm3 is associated with pulmonary cavitation, and on occasion with massive hemoptysis.

Entities:  

Mesh:

Year:  1985        PMID: 3966697     DOI: 10.1164/arrd.1985.131.1.115

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  18 in total

Review 1.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Authors:  Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack Sobel; Claudio Viscoli; Thomas J Walsh; Johan Maertens; Thomas F Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John R Graybill; Lindsey R Baden; Peter G Pappas; John E Bennett; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart-Jan Kullberg; William E Dismukes; Ben E De Pauw
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

2.  Epidemiology and Prevention of Invasive Aspergillosis.

Authors:  David W. Warnock; Rana A. Hajjeh; Brent A. Lasker
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

Review 3.  Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment.

Authors:  T J Walsh; D M Dixon
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

4.  Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings.

Authors:  Bo Da Nam; Tae Jung Kim; Kyung Soo Lee; Tae Sung Kim; Joungho Han; Myung Jin Chung
Journal:  Eur Radiol       Date:  2017-08-10       Impact factor: 5.315

Review 5.  Advances in the diagnosis of fungal pneumonias.

Authors:  Bryan T Kelly; Kelly M Pennington; Andrew H Limper
Journal:  Expert Rev Respir Med       Date:  2020-04-21       Impact factor: 3.772

Review 6.  Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature.

Authors:  P Eggimann; J-C Chevrolet; M Starobinski; P Majno; M Totsch; B Chapuis; D Pittet
Journal:  Infection       Date:  2006-12       Impact factor: 3.553

Review 7.  Aspergillus in the lung: diverse and coincident forms.

Authors:  Susan J Buckingham; David M Hansell
Journal:  Eur Radiol       Date:  2003-05-29       Impact factor: 5.315

8.  Invasive aspergillosis complicating induction chemotherapy of childhood leukaemia.

Authors:  T Bömelburg; N Roos; H J von Lengerke; J Ritter
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

Review 9.  Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients.

Authors:  C C Kibbler; S R Milkins; A Bhamra; M A Spiteri; P Noone; H G Prentice
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

10.  Pulmonary fungal infections after bone marrow transplantation.

Authors:  B T Allan; D Patton; N K Ramsey; D L Day
Journal:  Pediatr Radiol       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.